|1.||Szymusiak, Ronald: 4 articles (11/2015 - 05/2004)|
|2.||McGinty, Dennis: 4 articles (11/2015 - 05/2004)|
|3.||Kumar, Sunil: 2 articles (11/2015 - 07/2013)|
|4.||Gvilia, Irma: 2 articles (11/2015 - 09/2006)|
|5.||Guzman-Marin, R: 2 articles (10/2009 - 07/2004)|
|6.||Suntsova, N: 2 articles (10/2009 - 07/2004)|
|7.||Szymusiak, R: 2 articles (10/2009 - 07/2004)|
|8.||McGinty, D: 2 articles (10/2009 - 07/2004)|
|9.||Suntsova, Natalia: 1 article (11/2015)|
|10.||Alam, Md Noor: 1 article (07/2013)|
11/01/2015 - "Administration of CRF during acute sleep deprivation (SD) resulted in suppression of recovery sleep and decreased c-Fos expression in MnPN/VLPO GABAergic neurons. "
09/13/2006 - "Expression of c-Fos protein immunoreactivity (IR) in GABAergic neurons in the MnPN and the vlPOA is high in spontaneously sleeping rats and in rats undergoing recovery sleep after sleep deprivation. "
05/01/2004 - "They also demonstrate that sleep deprivation is associated with increased activation of GABAergic neurones in the MnPN and vlPOA."
09/01/2011 - "On Wistar rats in view of electrophysiological parameters after sleep deprivation (SD; awake by gentle handling method) and the subsequent postdeprivative sleep (PDS) immunohistochemical investigation of Bcl-2 and p53 peptides optical density levels in neurons of paraventricular (PVN), supraoptic (SON) and median (MnPN) hypothalamus nuclei was carried out. "
07/01/2013 - "Intracerebroventricular infusion of ZM-241385, an A2AR antagonist, during the last 2 h of a 3-h period of sleep deprivation caused suppression of subsequent recovery sleep and reduced Fos-IR in MnPN and VLPO GABAergic neurons. "
11/01/1991 - "Twice daily swabbing of the oral cavity of rats with aqueous solutions of MNPN or NNK for up to 61 weeks led only to one oral tumor in each group of 30 animals. "
11/01/1991 - "However, the application of MNPN to mouse skin led also to multiple distant tumors in the lungs of the animals. "
01/15/1987 - "MNPN at the higher dose induced 18 (86%) malignant tumors of the nasal cavity in male and 15 (71%) in female rats. "
09/01/1984 - "Upon subcutaneous injection of 1.1 mmol of MNPN in 60 subdoses, all of the 15 male and of the 15 female F344 rats developed tumors within 24 weeks. "
11/01/1991 - "On mouse skin, like the otherwise strongly carcinogenic, tobacco-specific 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), MNPN showed only weak local tumor initiator activity. "
|5.||Absence Epilepsy (Absence Seizure)
|3.||ZM 241385 (ZM241385)
|4.||4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanone